Scarica l'app Stockscreener
4.04
0.00%
0.00
Dopo l'orario di chiusura:
4.03
-0.010
-0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.04
Aprire:
$3.99
Volume 24 ore:
3.95M
Relative Volume:
1.70
Capitalizzazione di mercato:
$338.41M
Reddito:
$103.00K
Utile/perdita netta:
$-42.47M
Rapporto P/E:
-2.1263
EPS:
-1.9
Flusso di cassa netto:
$-34.30M
1 W Prestazione:
+0.25%
1M Prestazione:
+57.50%
6M Prestazione:
+85.32%
1 anno Prestazione:
+110.42%
Intervallo 1D:
$3.98
$4.05
Intervallo di 1 settimana:
$3.98
$4.06
Portata 52W:
$1.38
$4.50
Checkpoint Therapeutics Inc Stock (CKPT) Company Profile
Nome
Checkpoint Therapeutics Inc
Settore
Industria
Telefono
781-652-4500
Indirizzo
95 SAWYER ROAD, WALTHAM, NY
Confronta CKPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CKPT
Checkpoint Therapeutics Inc
|
4.04 | 338.41M | 103.00K | -42.47M | -34.30M | -1.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 68.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-13 | Iniziato | D. Boral Capital | Buy |
| 2022-07-14 | Ripresa | B. Riley Securities | Buy |
| 2021-06-09 | Iniziato | B. Riley Securities | Buy |
| 2021-01-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-05-29 | Iniziato | Lake Street | Buy |
| 2017-12-08 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Checkpoint Therapeutics Inc Borsa (CKPT) Ultime notizie
Checkpoint Therapeutics CEO sells stock for $60,963 - Investing.com
Checkpoint Therapeutics Executives Sell Shares for Tax Obligations - TradingView
Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan
Checkpoint Therapeutics Full Year 2024 Earnings: US$1.42 loss per share (vs US$1.87 loss in FY 2023) - Yahoo Finance
Checkpoint Therapeutics Reports 2024 Financial Results and Merger - TipRanks
Checkpoint Therapeutics Inc. (CKPT) reports earnings - Quartz
Checkpoint Therapeutics, Inc. SEC 10-K Report - TradingView
Checkpoint Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates - The Manila Times
Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan
GLAZER CAPITAL, LLC Acquires Significant Stake in Checkpoint The - GuruFocus
Beryl Capital Management LLC's Strategic Acquisition of Checkpoi - GuruFocus.com
Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Shift From Loss To Profit - Yahoo Finance
Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc.CKPT - Business Wire
Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million - MSN
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of ... - Bluefield Daily Telegraph
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire Inc.
10,081 Shares in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Bought by SBI Securities Co. Ltd. - Defense World
Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News - Mint
How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma? - Smartkarma
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (NasdaqCKPT), Redfin Corporation (NasdaqRDFN), Amplify Energy Corp. (NYSEAMPY), Blackboxstocks Inc. (NasdaqBL - Morningstar
Sun Pharma to Acquire Checkpoint Therapeutics in Oncology Expansion - Chemical Industry Digest
Checkpoint Therapeutics’ (CKPT) “Neutral” Rating Reaffirmed at HC Wainwright - Defense World
Checkpoint Therapeutics Target of Unusually Large Options Trading (NASDAQ:CKPT) - Defense World
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Major Acquisition Deal in Pharmaceutical Industry: Sun Pharma to Acquire Checkpoint Therapeutics - Dalal Street Investment Journal
Sun Pharma to acquire Checkpoint Therapeutics Inc for up to USD 355 mn - Press Trust of India
Sun Pharma shares rise over 2 pc as company to acquire Checkpoint Therapeutics - Press Trust of India
3 Penny Stocks to Watch Now, 11/3/25 - TipRanks
Checkpoint Therapeutics (NASDAQ:CKPT) Receives Hold Rating from Lake Street Capital - Defense World
Sun Pharma surges 3%. 3 reasons why Motilal Oswal has ‘Buy’ rating - The Financial Express
Sun Pharma to acquire oncology therapy company Checkpoint in US - domain-b.com
Checkpoint Therapeutics (NASDAQ:CKPT) Given Buy Rating at D. Boral Capital - Defense World
Sun Pharma to acquire a US-based oncology firm in a deal exceeding ₹3,000 crore - Bizz Buzz
Despite near-term challenges, brokerages remain positive on Sun Pharma - Business Standard
Sun Pharma to acquire US oncology compony for over Rs 3,000 crore - MSN
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - Longview News-Journal
Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump - Mugglehead
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Checkpoint Therapeutics, Inc.CKPT - The Malaysian Reserve
Small cap wrap: HIVE, North Bay Resources, GoviEx... - Proactive Investors UK
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details - AOL.com
Checkpoint Therapeutics shares pop on acquisition by Sun Pharma - Proactive Investors UK
Checkpoint Agrees To Sun Pharma Buyout: This Deal Suits Both Parties (NASDAQ:CKPT) - Seeking Alpha
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher - Benzinga
Sun Pharma to Acquire Checkpoint Therapeutics - Bilkul Online
Checkpoint Therapeutics jumps after deal to be acquired by Sun Pharma - TipRanks
Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target - Marketscreener.com
Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -- Checkpoint Shares Jump Monday - Marketscreener.com
Checkpoint Therapeutics Inc Azioni (CKPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):